Lanbo Xiao, PhD, of the Department of Pathology was recently awarded for his notable contributions in the areas of teaching, mentoring, service, and scholarship at the Faculty Award Celebration on October 30, 2025.
Prostate cancer relies on genetic “switches”, called enhancers, that can turn on tumor-promoting genes. Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B N-terminal acetylation (H2BNTac), an essential chemical mark of these enhancers.
The Department of Pathology is home to world-class faculty from around the world. One of these is Dr. Kejian Zhang, clinical professor and director of the molecular genetics laboratory in the Division of Genetics and Genomics. Zhang originally came to the United States to learn how to perform clinical research. “I started at the Cincinnati Children’s Hospital performing research in the Hematology Oncology department. I was there for seven or eight years before I started my fellowship in human genetics.
The Pathologist's Power List, released every year, recognizes individuals who are shaping the future of pathology and laboratory medicine. The 2025 honorees list is comprised of leading voices who challenge established ideas and advocate for reform. Among the honorees are Dr. Kamran Mirza, Godfrey D. Stobbe Professor of Pathology Education, Director of the Division of Education, and Co-Chair of the Patient and Faculty Advisory Committee, and Michele Mitchell, Patient Advocate and Co-Chair of the Patient and Faculty Advisory Committee.